Steven Madden stock reports Q2 growth as targets rise

Published on 09/29/2026 at 22:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Steven Madden stock posted USD 665.87 million in Q2 revenue, up 19.10 percent year over year. Analysts set a USD 51.80 average target on September 19, 2026.

SHOO, US8597301046, Illustration mit AI erstellt.

Steven Madden stock is backed by Q2 revenue of USD 665.87 million and a USD 3.3 billion market capitalization as of September 29, 2026. The footwear and accessories company also carries a Moderate Buy consensus and an average 12-month target of USD 51.80.

Q2 revenue grows 19.10 percent

According to MarketBeat, Steven Madden reported USD 665.87 million in Q2 revenue, up 19.10 percent from the same quarter a year earlier. The company also reported EPS of USD 0.44, compared with a USD 0.33 consensus estimate.

The earnings comparison is the key operating signal: Q2 EPS was USD 0.11 above consensus, while the prior-year quarter produced USD 0.20 per share. Fiscal 2026 guidance calls for EPS of USD 2.05 to USD 2.15, according to MarketBeat.

Analysts set targets above current range

MarketBeat reported a Moderate Buy consensus from ten analysts, including five Buy ratings, one Strong Buy, three Holds and one Sell. The average 12-month target was USD 51.80, while Citigroup raised its target from USD 45.00 to USD 55.00 on July 31, 2026.

The target spread shows the market debate clearly. UBS moved its target from USD 40.00 to USD 45.00 while retaining a Neutral rating, and Williams Trading set a USD 56.00 target, according to MarketBeat.

Market value reaches USD 3.3 billion

Steven Madden had a market capitalization of USD 3.3 billion on September 29, 2026. Its 52-week range was USD 31.33 to USD 49.70, placing the latest reported market context below the annual high and above the annual low.

The company designs, sources and markets branded and private-label footwear, accessories and apparel under labels including Steve Madden, Kurt Geiger London and Dolce Vita, according to its investor overview. Its Nasdaq listing uses the ticker SHOO.